KRTL BioTech

Latest News on private equity markets

Rate futures surge as coronavirus seen pushing Fed to ease

U.S. interest rates futures surged to their highest levels since last fall as a global sell-off in stocks and panicked buying of government bonds fueled growing expectations that the Federal Reserve will soon be forced to respond with interest rate cuts.



4 years ago

Warren Buffett calls Apple 'probably the best business I know in the world'

Warren Buffett told CNBC that Berkshire Hathaway's "third largest business," after its insurance and railroad interests, is its stake in Apple.

4 years ago

SoftBank leads $265 million investments in two U.S.-based start-ups

SoftBank on Monday led a new funding round of $165 million in California-based Karius and invested $100 million in New York-headquartered AI company Behavox, as the technology giant builds a portfolio under its second Vision Fund.



4 years ago

The move you want to avoid making as coronavirus sinks the markets

As coronavirus fears send the Dow Jones Industrial Average down triple digits, there's one move you want to avoid making. Here's the mistake one behavioral finance expert says investors are most susceptible to at these times — and what you should do instead.

4 years ago

Here's how much money you give up if you don't grab your employer's 401(k) match

Depending on your salary and the matching formula used by your company, your employer's contribution to your 401(k) could translate into thousands of extra dollars going toward your nest egg every year.

4 years ago

Bank of America names Morisseau as head of investment banking for France: memo

Bank of America has appointed Jérôme Morisseau as its head of investment banking for France as it seeks to build out its French franchise and win more business from large French clients, a memo seen by Reuters said.



4 years ago

Sanofi to create active pharmaceutical ingredients business

Sanofi said on Monday it intended to create a standalone company dedicated to the production of active pharmaceutical ingredients.



4 years ago

European shares suffer worst day since 2016 as virus spreads, Wall Street opens ugly

European shares suffered their biggest slump since mid-2016 on Monday and oil plunged almost 5%, as a jump in coronavirus cases in Italy, South Korea, Japan and Iran sent investors scrambling to the security of gold and government bonds.



4 years ago

Dow sheds 800 points as pandemic fears grip Wall Street

The Dow Jones Industrials shed 800 points on Monday as investors scurried to safer assets after a sharp rise in coronavirus cases outside China fueled fears of a bigger impact to global growth.



4 years ago

Growth in Canadian FinTechs Having Impact on Canada’s Banking Landscape

TransUnion Canada | Release | Feb 24, 2020 New TransUnion study considers common myths around the profile of FinTech borrowers in Canada FinTechs are not just attracting younger Canadians: 46% of FinTech borrowers are over the age of 40 Short-term loans are not the primary focus for FinTechs: 88% of FinTech loan terms are between

4 years ago

Pandemic fears grip Wall Street, Dow dives 800 points

The Dow Jones Industrials fell more than 800 points and the S&P 500 as well as the Nasdaq hit three-week lows on Monday as a surge in coronavirus cases outside China fueled global growth worries and pushed investors to safer assets.



4 years ago

Exclusive: Hedge fund Third Point targets British insurer Prudential - sources

Hedge fund Third Point LLC has amassed more than a $2 billion stake in Prudential Plc and plans to push Britain's biggest insurer to split into two companies, people familiar with the matter said on Monday.



4 years ago

Canceled Teck oil sands project underscores global climate-energy policy tension

Teck Resources Ltd's surprise decision to cancel a planned C$20.6 billion ($15.6 billion) oil sands mine in northern Alberta, citing uncertainty about Canada's climate policy, underscores a global struggle to balance energy growth with environmental concerns.



4 years ago

France's Sanofi to carve out active drug ingredients firm

Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically active in a drug, and will decide whether to list it on Euronext Paris by 2022.



4 years ago

History shows stocks typically rebound from disease outbreaks before long

Your 401(k) likely isn't recovering from the coronavirus as quickly as you'd hoped. Yet history shows stocks typically rebound from outbreaks before long.

4 years ago